IBEX (NASDAQ:IBEX) CEO Robert Thomas Dechant Sells 25,000 Shares of Stock

IBEX Limited (NASDAQ:IBEXGet Free Report) CEO Robert Dechant sold 25,000 shares of IBEX stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $39.99, for a total value of $999,750.00. Following the completion of the transaction, the chief executive officer owned 262,011 shares of the company’s stock, valued at approximately $10,477,819.89. The trade was a 8.71% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

IBEX Trading Down 1.3%

Shares of NASDAQ IBEX opened at $40.28 on Thursday. IBEX Limited has a twelve month low of $25.94 and a twelve month high of $42.40. The company has a market capitalization of $534.92 million, a price-to-earnings ratio of 12.87 and a beta of 0.72. The business has a 50 day simple moving average of $36.41 and a 200-day simple moving average of $32.05.

IBEX (NASDAQ:IBEXGet Free Report) last announced its quarterly earnings data on Thursday, September 10th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.01. The firm had revenue of $164.27 million for the quarter, compared to analysts’ expectations of $160.02 million. IBEX had a return on equity of 28.96% and a net margin of 7.19%.

Wall Street Analyst Weigh In

IBEX has been the topic of a number of recent research reports. Robert W. Baird raised their price target on shares of IBEX from $35.00 to $40.00 and gave the stock a “neutral” rating in a research report on Friday, September 11th. Wall Street Zen lowered shares of IBEX from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 12th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of IBEX in a report on Friday, July 31st. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, IBEX currently has a consensus rating of “Hold” and an average price target of $40.00.

View Our Latest Stock Analysis on IBEX

Institutional Investors Weigh In On IBEX

A number of hedge funds have recently added to or reduced their stakes in IBEX. Tieton Capital Management LLC purchased a new stake in IBEX in the 2nd quarter worth about $8,353,000. Globeflex Capital L P acquired a new position in shares of IBEX during the 2nd quarter worth $3,112,000. Y Intercept Hong Kong Ltd raised its holdings in shares of IBEX by 121.8% during the 1st quarter. Y Intercept Hong Kong Ltd now owns 95,665 shares of the company’s stock valued at $2,566,000 after purchasing an additional 52,526 shares in the last quarter. Lazard Asset Management LLC lifted its stake in shares of IBEX by 55.2% in the 1st quarter. Lazard Asset Management LLC now owns 89,150 shares of the company’s stock valued at $2,391,000 after purchasing an additional 31,697 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in IBEX by 7.5% in the first quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company’s stock worth $9,607,000 after purchasing an additional 24,942 shares in the last quarter. 81.24% of the stock is currently owned by institutional investors.

Key Headlines Impacting IBEX

Here are the key news stories impacting IBEX this week:

  • Positive Sentiment: IBEX announced that it won a 2026 Globee Award for excellence in an AI-powered customer-experience solution. The recognition supports the company’s positioning in the growing AI-enabled business-process-outsourcing market. ibex Wins 2026 Globee Award for AI-Powered Customer Experience Solution Excellence
  • Positive Sentiment: Recent reports highlight IBEX’s efforts to use AI solutions to gain market share and adjust its delivery mix between nearshore and offshore operations. These initiatives could improve scalability, service capabilities and margins if executed successfully. IBEX touts AI solutions to grow market share IBEX shifts from nearshore to offshore
  • Positive Sentiment: IBEX’s latest quarterly results modestly exceeded expectations, with earnings per share of $0.85 versus an $0.84 consensus and revenue of $164.27 million versus estimates of $160.02 million. The company reported a 7.19% net margin and 28.96% return on equity.
  • Neutral Sentiment: Analyst sentiment remains cautious: Robert W. Baird raised its price target to $40 but kept a neutral rating, while the consensus rating is “Hold” with an average target of $40. The stock’s recent advance has placed it close to that consensus valuation.
  • Negative Sentiment: Multiple insiders sold shares around $39.34–$40.41, including CEO Robert Dechant, COO David Afdahl, directors Mingzhe Zhuang and Daniella Ballou-Aares, and other insiders. The sales totaled more than 56,000 shares across the disclosed transactions and reduced several holdings substantially, creating a negative insider-ownership signal. Some transactions, including sales by Dechant, Afdahl and Paul Inson, were made under pre-arranged Rule 10b5-1 plans. SEC insider transaction filing

IBEX Company Profile

(Get Free Report)

IBEX Limited (NASDAQ: IBEX) is a global business process outsourcing and customer experience company. It provides digitally enabled customer support and operational services for brands across industries including e-commerce, health and fitness, fintech, logistics, retail, travel and utilities.

The company’s services include customer care, technical support, sales and customer acquisition, back-office processing, trust and safety, and other specialized business support functions. IBEX combines contact center personnel, analytics, automation and artificial intelligence-enabled tools to help clients manage customer interactions across voice, digital and other communication channels.

IBEX serves clients primarily in North America and other international markets through delivery operations in locations including the United States, the Philippines, Jamaica, Nicaragua and Pakistan.

Read More

Insider Buying and Selling by Quarter for IBEX (NASDAQ:IBEX)

Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.